Exelixis

exelixis.com

Exelixis is a multi-platform cancer company dedicated to discovering, developing, and commercializing innovative therapies for cancer treatment. With a focus on small molecules and biotherapeutics, Exelixis has developed a diversified portfolio of cancer treatments, including its flagship product CABOMETYX® (cabozantinib). The company leverages deep expertise in chemistry and biology, along with strategic partnerships, to advance its pipeline of next-generation therapies. Exelixis aims to redefine cancer care through innovative drug discovery and development, providing hope to patients and striving for a potential cure.